Crystalline pharmaceutical and methods of preparation and use thereof

Inventors: John Burnier (Pacifica, CA); Thomas Gadek (Oakland, CA); Frederic Naud (Binningen, CH)

Assignee: SARcode Bioscience Inc.

C07D217/26 A61K31/4709 C07D405/06

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,871,935
App. No.: 13/710,651
Granted: Oct 28, 2014
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.

Claims (6)

1. A method of synthesizing a compound of Formula I:

comprising the steps:

a) hydrogenolyzing an ester of Formula A with a palladium catalyst and a source of protons; and

b) isolating a compound of Formula I.

2. The method of claim 1 , wherein the palladium catalyst is 10% palladium on carbon.

3. The method of claim 1 , wherein the proton source is formic acid.

Assignments (8)

INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025

From: BAUSCH + LOMB IRELAND LIMITED

To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT

Reel/Frame 074050/0573 →